Image Credit: Canva
The human eye has long been considered a window to the soul, but modern science reveals its potential for being a diagnostic window toward our health. Researchers have already discovered that in the retina – the light-sensitive layer at the back of the human eye – resides an intricate network of blood vessels that can foretell crucial elements about a person's risk to stroke. This finding is a non-invasive and accessible approach to predicting stroke, hence challenging the dependency on the classic risk factors alone, such as high cholesterol or blood pressure. Recent research published in the journal Heart identified a "vascular fingerprint" in the retina, comprising 29 indicators of blood vessel health.
This fingerprint can predict the likelihood of a stroke with accuracy comparable to conventional methods. These indicators include characteristics like the density, twistedness, and complexity of retinal veins and arteries, which mirror the vascular architecture of the brain.
This innovative approach is particularly promising for primary healthcare settings and resource-constrained environments, where invasive lab tests may not be feasible. The potential to assess stroke risk through a simple retinal scan marks a significant leap in preventive medicine.
The researchers, who include those from The Royal Victorian Eye and Ear Hospital in Australia, analyzed fundus images, which are specialized photographs of the retina from more than 68,000 participants in the UK Biobank dataset. Over an average follow-up period of 12.5 years, 749 of those participants had a stroke.
The researchers used advanced machine learning models, such as the Retina-based Microvascular Health Assessment System (RMHAS), to study 30 indicators in five key categories of retinal vascular architecture.
These categories included calibre, which measured the length, diameter, and ratio of veins and arteries; density, which focused on the distribution of blood vessels in the retina; twistedness, analyzing the curvature and patterns of the vascular network; branching angle, which examined how veins and arteries split into smaller branches; and complexity, which evaluated the overall intricacy of the vascular network. In the study, age, sex, socioeconomic status, lifestyle habits, and health parameters, including blood pressure and cholesterol levels, were taken into account to ensure that the findings were robust. The analysis showed that 29 out of 118 retinal vascular indicators are significantly associated with first-time stroke risk.
Changes in density indicators corresponded to 10-19% increased risks of stroke; alterations in calibre indicators were accompanied by a 10-14% increase. Other studies have suggested that decreases in complexity and twistedness indicators corresponded to a 10.5-19.5% higher risk of stroke. These data support the retinal imaging non-invasive diagnostic tool for prediction of early stroke.
Amazingly, the retinal vascular fingerprint alone, in combination with only age and sex, was as good at predicting stroke risk as traditional methods that rely on invasive tests.
Retinal blood vessels bear anatomical and physiological resemblance to those in the brain. Given this, it is an attractive organ for understanding the systemic health of the vasculature. Many diseases, for example, which damage blood vessels throughout the body, leave evidence in the retinal microvascular network. Diabetic retinopathy and hypertensive retinopathy are examples.
The study does have several limitations with this being an observational research, and so it cannot claim to establish any cause-and-effect relationships. The research was also primarily conducted on whites, which makes the findings a little less generalizable to a diverse population. Future studies would be better in including a range of ethnicities and exploring the risk of stroke associated with the type of stroke.
Traditional stroke risk assessment is often confined to blood studies and imaging studies; however, these tools are not freely available in some low-resource settings. Retinal photography provides a completely non-invasive imaging modality. All that will be needed will be a basic photograph of an eye.
It is, therefore, through the introduction of artificial intelligence that has been a game-changer in retinal imaging. Systems like RMHAS rely on machine learning to pick out patterns and biomarkers that the human eye might not identify. Such improvements not only enhance predictive accuracy but also speed up the process while making it more cost-effective.
Also Read: 3 Shocking Stroke Risk Factors You Need To Control NOW
Stroke is one of the leading global health concerns, causing nearly 100 million cases a year and killing 6.7 million people. The majority of the cases are due to modifiable risk factors, including high blood pressure, poor diet, and smoking. The early warning system could help individuals and healthcare providers act proactively on these risks by providing an early warning system.
The discovery of the vascular fingerprint of the retina as a predictor of stroke risk is a testament to the power of innovative diagnostics. This non-invasive, accessible method may revolutionize stroke prevention, especially in underserved communities. As research continues to refine this approach and broaden its applicability, the eye may soon become an essential tool in safeguarding our brain health.
The good news is that strokes can be prevented in most cases by living a healthy lifestyle, coupled with knowing the early warning indicators. Implement these tips daily and prevent your risk for stroke before it gets too late.
- High blood pressure is one of the leading risk factors for stroke. Uncontrolled hypertension can weaken blood vessels, making them more prone to rupture or blockage. Invest in a home blood pressure monitor to check your readings regularly. Maintain a target of 120/80 mmHg by reducing salt intake, staying physically active, and adhering to prescribed medications.
- Unhealthy eating habits, such as diets with high levels of processed foods, saturated fats, and cholesterol, can lead to obesity and blocked arteries. A diet rich in fruits, vegetables, whole grains, lean protein, and healthy fats is key. Include leafy greens, berries, nuts, and fish high in omega-3s, which help maintain cardiovascular health.
- Regular physical activity lowers the risk of high blood pressure, obesity, and diabetes, three leading causes of stroke. Try to engage in at least 150 minutes of moderate-intensity aerobic activity a week. Examples include brisk walking, cycling, or swimming. Also incorporate strength training to help strengthen your blood vessels.
- Smoking harms your blood vessels, promotes blood clots, and reduces the oxygen in your blood. Overconsumption of alcohol can raise your blood pressure and lead to weight gain. Quit smoking with support groups, counseling, or nicotine replacement therapy. Limit your intake of alcohol to moderate levels; that is, one drink a day for women and two for men.
- Unmanaged conditions, such as diabetes, high cholesterol, and atrial fibrillation, significantly increase stroke risk. Work with your healthcare provider to monitor and manage these conditions. For example, maintain blood sugar levels within target ranges for diabetes and take anticoagulants if diagnosed with atrial fibrillation.
- Obesity strains the cardiovascular system and increases the risk for stroke. Have a healthy diet along with regular exercise to have a sustainable weight loss. Small, consistent changes in, say, portion control or simply not having too many sugary drinks may make a big difference.
- As a result of this, dehydration could thicken blood, then clots might form. Drink at least 8-10 glasses of water per day. Include hydrating foods like cucumbers and watermelon in your diet, especially during hot weather or exercise.
- Poor sleep quality increases blood pressure, triggers inflammation, and raises stroke risk. Ensure 7-8 hours of sleep at night. Develop a bedtime routine: reduce screen time, have a regular schedule, and avoid caffeine close to bedtime.
- Acting fast during a stroke can prevent long-term damage and save lives. Learn the FAST acronym:
F: Face drooping
A: Arm weakness
S: Difficulty speaking T: Time to call 911
- Regular medical check-ups can identify and manage stroke risk factors before they lead to a stroke. Make an annual physical to track cholesterol, blood pressure, and other essential health markers. If you have a family history of stroke, discuss retinal imaging or carotid artery screening with your physician.
Retinal vascular fingerprints predict incident stroke: findings from the UK Biobank cohort study. Heart. 2025
Credits: Canva
When it comes to medicine, it has been time and again proven that women bodies have been studied way less. This is why, even after science being this advance, has often lacked on how women's bodies react to different illness and their cures. It is the same in the case of Tourette syndrome. As per a study published in Neurology, there is an existing gender gap in diagnosing Tourette syndrome (TS).
Researchers have also found that women are not only less likely to be diagnosed with TS, but also experience longer delays in receiving a diagnosis. These findings, led by Dr. Marisela Elizabeth Dy-Hollins of Massachusetts General Hospital, highlight the urgent need for increased awareness and early screening of TS in females.
Tourette syndrome is a neurodevelopmental disorder characterized by involuntary, repetitive movements and sounds, known as tics. These can include simple actions like blinking or throat clearing, as well as more complex behaviors such as jumping or repeating words. Tics must persist for at least a year for a diagnosis of TS or persistent motor or vocal tic disorder, where only movement or vocal tics are present.
Although TS is diagnosed about three times more often in males than females, the study suggests that this gap may not purely reflect biological differences. Instead, it may indicate that females are being underdiagnosed or diagnosed later due to differences in symptom presentation or societal biases.
Analyzing data from 2,109 people with TS and 294 with persistent motor or vocal tic disorder, the study revealed several important gender differences:
Diagnosis Rates: Only 61% of female participants had received a TS diagnosis before participating in the study, compared to 77% of males.
Delayed Diagnosis: On average, it took three years from symptom onset for females to be diagnosed, compared to two years for males.
Age at Diagnosis: Girls were typically diagnosed at an average age of 13, while boys were diagnosed around age 11.
Symptom Onset: Female participants showed slightly later onset of TS symptoms, around 6.5 years old compared to 6 years for males. However, for persistent motor or vocal tic disorder, symptoms actually appeared earlier in females (7.9 years) than males (8.9 years).
A limitation noted by researchers is that most participants were white, which may affect how broadly the findings can be applied across other racial and ethnic groups.
"These results suggest that healthcare professionals and parents should actively screen female individuals with tics to give them a better chance of managing symptoms over time," Dr. Dy-Hollins emphasized. Treatment strategies can vary and include:
Education: Teaching families, teachers, and patients about TS to reduce stigma and encourage early help-seeking.
Behavioral Therapies: Approaches like Comprehensive Behavioral Intervention for Tics (CBIT) can significantly help in managing symptoms.
Medications: In severe cases, medicines such as antipsychotics or muscle relaxants may be prescribed.
Watchful Waiting: Mild tics sometimes lessen over time without the need for intensive intervention.
Emotional Support: Addressing the psychological impact of TS is crucial for better overall well-being.
Researchers believe differences in how tics present in girls and societal expectations may contribute to the delayed or missed diagnoses. Dr. Dy-Hollins stressed the importance of further research, particularly studies involving more diverse populations. Raising awareness and ensuring equitable healthcare practices are vital to better support all individuals living with Tourette syndrome.
Credits: Canva
We know it’s a bit personal — but if you're sitting on the toilet right now, reading this, it’s time to rethink your bathroom strategy. Surprisingly, grunting your way through a bowel movement may be doing you more harm than good. Medical experts are now warning that the all-too-common habit of straining with sounds may actually make it harder for you to "go."
But if grunting doesn’t work, what does? Recent research is shining a light on an “interesting” — and more effective — position that could finally make bathroom time easier and healthier. Here’s everything you need to know.
While it might feel natural to push and grunt when you're struggling, studies show it’s not actually helping. In fact, releasing air and sound while straining reduces internal pressure, which is crucial for moving stool along.
When you grunt, you’re essentially letting out the very force that should be helping you pass stool. It's like trying to blow up a balloon with a leaky hole — the energy escapes instead of building pressure where it's needed most. This subtle loss of abdominal pressure means the effort you're making is, ironically, working against you.
A UK report even found that about a third of people are habitual loo-grunters. While it’s not going to cause immediate damage, it certainly won’t make things any easier.
The conversation around healthy pooping habits took off globally with the introduction of devices like the Squatty Potty — a footstool designed to help you squat rather than sit during bowel movements. The buzz wasn’t just marketing hype; there’s real science behind it.
Humans, after all, were not designed to defecate while sitting. Evolutionary biology suggests that squatting is the body's natural position for elimination. When we sit, the puborectalis muscle — which wraps around the rectum like a sling — stays partially tense, creating a bend (like a kink in a garden hose) between the rectum and anus to prevent unwanted accidents. Squatting relaxes this muscle fully, straightening out the digestive tract and allowing for smoother, more complete bowel movements.
In other words, sitting keeps your "hose" bent; squatting straightens it out and lets everything flow.
A study published in Digestive Diseases and Sciences by researcher Dov Sikirov measured the time and effort needed for bowel movements in different positions. The findings were clear:
The benefits aren’t just about convenience either. Straining during bowel movements is a known contributor to constipation, hemorrhoids, and even pelvic floor issues. Cultures where squatting toilets are the norm, such as in parts of Asia and Africa, report lower rates of these problems, although diet may also play a role.
The Squatty Potty and similar products are simple footstools designed to elevate your knees above your hips while you're seated. This change mimics a squat position, relaxing the puborectalis muscle and straightening out the colon.
While you could technically squat without buying anything — simply by bending deeply at the knees and hips — the stool makes the position much easier to achieve, especially for older adults or those with mobility issues.
And yes, evidence shows it works. People using posture-changing devices report less straining, faster bathroom visits, and a greater sense of “full evacuation.” If you’ve ever left the toilet feeling like you weren’t quite done, a squat stool might be your solution.
Western toilets prioritize comfort and decorum over functional anatomy. But if you find yourself frequently constipated, straining, or dealing with hemorrhoids, your toilet posture might be part of the problem.
Squatting isn't just about easier elimination — it’s about long-term digestive health. By relieving pressure during bowel movements, you can potentially lower your risk for common and painful conditions like:
When waste moves out of the body more easily, it also means less trapped stool, less bloating, and potentially better gut health overall.
If you're still not convinced, here’s why adopting a squatting posture could change your bathroom experience for good:
Reduces Straining: Prevents excessive pushing and lowers the risk of hemorrhoids.
Unkinks Your Colon: Straightens the rectal canal for a smoother passage.
Increases Full Evacuation: Helps you feel more empty after using the bathroom.
Relaxes Your Body Naturally: Aligns with the body's natural anatomy for easier elimination.
Next time nature calls, skip the grunt-fest and rethink your position. Whether you invest in a Squatty Potty or simply use a low footstool to prop up your legs, small changes can lead to big relief.
Modern toilets may have revolutionized hygiene, but when it comes to the natural way to poop, a little squatting can go a long way toward improving your gut health and making every bathroom trip a whole lot easier.
If you've heard the chatter about weight loss jabs and injections like Ozempic showing up in pediatrics, you're not alone — and you're likely full of questions. Are they safe for kids? Are they really effective? Or are we rushing into something without knowing the risks?
While childhood obesity rates continue to rise in the U.S., parents and doctors are looking at all possible ways to help kids with weight issues and that now includes GLP-1 receptor agonists, a type of medication first developed for adults with type 2 diabetes. Before making assumptions, though, it's worth taking a closer look at what the latest studies actually report about prescribing these medications to children and adolescents.
Childhood obesity has reached epidemic levels worldwide, threatening the health of millions of young lives. With conventional interventions proving to be of limited value, the question on everyone's mind is: might highly effective weight-loss drugs such as Ozempic (semaglutide) be a safe option for children? As researchers investigate this potential, a heated controversy has erupted, balancing the promise of pharmacological intervention against its deep uncertainties.
Rates of obesity among youth have risen astronomically in the last several decades. Since 1975, global rates of obesity have increased threefold, while childhood and adolescent rates have risen nearly fivefold, as reported by the World Health Organization. In the United States alone, close to 20% of children aged under 18 have obesity—a condition that has been linked with a plethora of lifetime health dangers, including type 2 diabetes, cardiovascular disease, chronic kidney disease, and severe mental illness.
Likewise, in the UK, data from the NHS in 2022 reported that 15% of children aged between 2 and 15 were considered obese. If not treated, projections by the World Obesity Federation estimate that 250 million children worldwide may be suffering from obesity by 2030. It's not only medical but also economic—lifetime healthcare expenses for addressing childhood obesity in the U.S. can be as much as $20,000 more than their healthy-weight peers.
Glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic and Wegovy have transformed the treatment of adult obesity. These drugs simulate a natural hormone that slows down gastric emptying, enhances sensations of fullness, and suppresses appetite. In adults, GLP-1 treatments have shown impressive advantages not just for weight loss but also for diseases like type 2 diabetes, heart disease, and even Alzheimer's disease, potentially.
As a result of their success in adults, researchers have been looking to see if such benefits can translate to children. A landmark study in 2022 in the New England Journal of Medicine enrolled 201 teens between the ages of 12 and 17. Following 68 weeks of once-weekly injections of semaglutide plus lifestyle intervention, 62% of those enrolled lost at least 10% of their weight, whereas only 8% of those receiving a placebo did. More than half had lost 15% or more of their weight, highlighting the efficacy of the drug.
It is to be expected that parents would worry about adding medications such as GLP-1 agonists — including Ozempic — to their child's treatment regimen. Recent research has determined that while GLP-1 injections are very effective in helping adolescents who have obesity lose weight, they do have side effects. The most often reported are nausea, vomiting, diarrhea, and abdominal pain. Fatigue and dizziness are also experienced by some children as their body adapts to the medication.
Studies in medical literature point out that although these side effects are usually tolerable, the long-term effect of GLP-1 administration in young, developing bodies is still under assessment. Clinical trials to date indicate that the majority of side effects are mild to moderate and decrease over time. Nevertheless, serious but rare risks such as pancreatitis and gallbladder disease have been reported, emphasizing the need for continued medical monitoring.
Regulatory agencies are gradually embracing these findings in the wake of this. Ozempic itself is not yet approved for pediatric use, but a higher-dose formulation of semaglutide called Wegovy was approved by the FDA in 2022 for adolescents 12 years and above with obesity.
Canada recently revised its national guidelines, suggesting that children as young as 12 might be candidates for GLP-1 therapies if lifestyle interventions alone are not enough. The new guidelines, developed by more than 50 experts and including feedback from families with obesity, focus on a comprehensive approach: integrating behavioral strategies with pharmacologic or surgical approaches when needed.
Despite growing enthusiasm, the use of Ozempic in young populations remains highly controversial. Critics argue that the long-term safety of GLP-1 agonists in children is unknown. Studies to date have been limited in scope, largely industry-sponsored, and have not adequately measured potential psychological side effects, including risks of disordered eating and body dissatisfaction.
Youngsters and adolescents are especially at risk. The body changes of adolescence, along with strong social demands, make adolescent weight control tricky. Specialists alert that medicalizing weight loss at this pivotal time of development potentially has unforeseen mental health costs, including increased vulnerability to eating disorders, worry, and despondency.
Additionally, there are no long-term data on the effects of these drugs on growth, hormonal development, or future fertility. In recognition of these uncertainties, the U.S. Preventive Services Task Force has suggested against the routine use of weight-loss medications in children due to a lack of evidence of long-term safety.
Structured lifestyle interventions—focusing on diet, exercise, and behavioral modification—are currently the first-line management of childhood obesity. They are only abandoned when these prove unsuccessful, and more intrusive measures, such as pharmacotherapy or bariatric surgery, are then sought. Conventional methods have found it difficult to achieve success, though, considering the environmental and socio-economic determinants affecting a child's capacity for a healthy way of living.
Obese adolescents are frequently bullied, stigmatized, and subject to systemic barriers that reinforce their condition. These events not only complicate weight loss but also contribute to severe mental health issues, such as self-injury and suicidal thoughts.
When managing childhood obesity, pediatricians emphasize that weight loss injections such as Ozempic are not meant to be a magic pill. Specialists highlight that Ozempic is intended to complement not substitute for improved eating habits, more physical activity, and emotional balance.
Pediatricians encourage parents to understand that obesity is a complex, chronic illness that is typically driven by genetics, environment, and behavior. Weight loss shots can be a useful tool for kids with severe obesity, particularly when standard therapies have failed. But physicians warn that unless the underlying causes — including diet, screen time, and mental health — are tackled, the rewards of Ozempic may not last long.
Although GLP-1 receptor agonists represent an exciting new agent for the treatment of pediatric obesity, their introduction should be carefully considered. Physician experts recommend scrupulous selection of patients, thorough counseling, and regular follow-up to confirm that medications form part of an overall supportive plan of care to meet physical as well as psychologic needs.
Additional independent, long-term research is essential to truly appreciate the consequences of prescribing drugs such as Ozempic to children. As the situation continues to change, clinicians, families, and policymakers need to weigh the imperative to treat the obesity epidemic against the moral obligation to protect children's future health.
In the meantime, the application of Ozempic and other such drugs to adolescents is a promising but complicated territory one that requires cautious deliberation, intense study, and an unwavering commitment to placing children's health interests above all else.
© 2024 Bennett, Coleman & Company Limited